At Arc Institute, we blend our academic side with a technical staff structured more like industry, aiming to create a model that others might want to replicate.

At Arc Institute, I look for individuals who think about science outside of the lab, have completed end-to-end projects, and possess the grit to see things through to completion.

ARC aims to foster long-term research capabilities and breakthroughs in biology by leveraging multidisciplinary expertise and long-term thinking.

We aim to create technologies and platform capabilities that are broadly useful, enabling new mechanistic insights and potentially curing diseases.

There's significant potential for breakthroughs by merging different subject areas, and I've always aimed to be multidisciplinary in my own work, integrating neuroscience, machine learning, and computer science.

Our goal is to solve all diseases by leveraging AI to transform our understanding of biology and chemistry, enabling us to manipulate and craft solutions effectively.

Our internal drug design projects focus on immunology and oncology, and we've made significant progress using advanced models.

At Isomorphic Labs, we collaborate with various companies to generate proprietary data, which has proven to be impactful in drug development.

Our sister company, Isomorphic Labs, is developing technologies around AlphaFold to design drug compounds that bind to specific parts of protein surfaces, which is crucial for understanding diseases.